News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Toledano Miranda Jayne
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/21/2023 |
4
| Toledano Miranda Jayne (Director) has filed a Form 4 on NEXGEL, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.05, valued at
$30.8k
|
|
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2023 |
4
| Toledano Miranda Jayne (CEO) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Bought 30,000 shares
@ $1.01, valued at
$30.3k
|
|
| 09/09/2022 |
4
| Toledano Miranda Jayne (CEO) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Granted 500,000 options to buy
@ $2.02, valued at
$1M
Granted 600,000 options to buy
@ $1.4, valued at
$840k
|
|
| 07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Toledano Miranda Jayne (Director) has filed a Form 4 on Journey Medical Corp|
Txns:
| Granted 30,000 shares
@ $0 |
|
| 01/19/2022 |
4
| Toledano Miranda Jayne (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Bought 6,800 shares
@ $2.7899, valued at
$19k
|
|
| 01/11/2022 |
4
| Toledano Miranda Jayne (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Granted 35,852 options to buy
@ $2.815, valued at
$100.9k
Granted 107,557 options to buy
@ $2.815, valued at
$302.8k
|
|
| 01/11/2022 |
3
| Toledano Miranda Jayne (Director) has filed a Form 3 on Entera Bio Ltd. |
| 01/03/2022 |
4
| Toledano Miranda Jayne (Director) has filed a Form 4 on NEXGEL, INC.|
Txns:
| Bought 1,819 shares
@ $5.49, valued at
$10k
Granted 1,819 options to buy
@ $5.5, valued at
$10k
|
|
| 11/26/2021 |
3
| Toledano Miranda Jayne (Director) has filed a Form 3 on Journey Medical Corp |
| 09/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/29/2021 |
4
| Toledano Miranda Jayne (Director) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Acquired 1,791,549 shares
@ $0
Granted 50,000 options to buy
@ $4.9, valued at
$245k
|
|
| 06/29/2021 |
3
| Toledano Miranda Jayne (Director) has filed a Form 3 on Compass Therapeutics, Inc. |
| 10/05/2016 |
3
| Toledano Miranda Jayne (EVP-Corporate Development) has filed a Form 3 on Sorrento Therapeutics, Inc. |
|
|